• OPEN AN ACCOUNT
Indian Indices
Sensex
83,576.24 -604.72
( -0.72%)
Global Indices
Nasdaq
49,520.87 233.75
(0.47%)
Dow Jones
6,986.78 44.32
(0.64%)
Hang Seng
51,918.01 800.75
(1.57%)
Nikkei 225
10,123.15 78.46
(0.78%)
Forex
USD-INR
89.91 -0.02
(-0.02%)
EUR-INR
104.90 -0.20
(-0.19%)
GBP-INR
120.86 -0.43
(-0.35%)
JPY-INR
0.57 0.00
(-0.15%)

EQUITY - MARKET SCREENER

Torrent Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
500420
INE685A01028
249.8252811
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TORNTPHARM
62.84
134120.85
EPS(TTM)
Face Value()
Div & Yield %
63.06
5
0.15
 

RailTel Corp bags Rs 35-cr order from BMC for communication solution
Dec 12,2025
The project is scheduled to be executed by 10 March 2031.

RailTel Corporation, a 'Navratna' PSU, is one of the largest neutral telecom infrastructure providers in the country, owning a Pan-India optical fiber network.

The company’s standalone net profit jumped 4.72% to Rs 76.07 crore in Q2 FY26, compared with Rs 72.64 crore in Q2 FY25. Revenue from operations rose 12.78% YoY to Rs 951.36 crore in Q2 FY26.

The counter shed 0.02% to Rs 332.10 on the BSE.